Table I.

Characteristics of prostate cancer patients (n=98).

Clinicopathological feature	Value
Age
Median, years	63
Range, years	54–83
Preoperative prostate-specific antigen (ng/ml), n
﹤4	17
4–10	63
≥10	18
Gleason score, n
6	33
7	54
8	6
9	5
Pathological tumor stage, n
pT2	68
pT3	25
pT4	5
Follow-up, months
Median	45
Range	1–128
Biochemical recurrence (months), n	18
1–12	7
13–24	6
>24	5